Cardiac autonomic nervous activity during different sleep stages in individuals with spinal cord injury: The influence of physical training

OBJECTIVE

The present study assessed the influence of physical training on cardiac autonomic activity in individuals with spinal cord injury (SCI) during different sleep stages.

METHODS

Twenty-six volunteers were allocated into three groups: 9 sedentary individuals without SCI (control, CON); 8 sedentary tetraplegic individuals with chronic SCI (SED-SCI); 9 physically trained tetraplegic individuals with chronic SCI (TR-SCI). All participants underwent nocturnal polysomnography to monitor sleep stages: wakefulness, non-rapid eye movement (NREM) sleep (N1, N2, and N3 stages), and REM sleep. The electrocardiography data obtained during this exam were extracted to analyze the heart rate variability (HRV).

RESULTS

Sleep stages influenced HRV in the time [RR interval and root mean square of successive RR interval differences (RMSSD)] and frequency [low-frequency (LF) and high-frequency (HF) powers and LF-to-HF ratio] domains (P < 0.05). SED-SCI individuals showed unchanged HRV compared to CON (P > 0.05). When comparing the TR-SCI and SED-SCI groups, no significant differences in HRV were reported in the time domain (P > 0.05). However, in the frequency domain, more accentuated HF power was observed in TR-SCI than in SED-SCI individuals during the N2 and N3 stages and REM sleep (P < 0.05). Moreover, TR-SCI had higher HF power than CON during the N3 stage (P < 0.05).

CONCLUSIONS

TR-SCI individuals have greater HF power, indicative of parasympathetic modulation, than sedentary (injured or not injured) individuals during different sleep stages. Therefore, enhanced parasympathetic activity induced by physical training may improve cardiac autonomic modulation during sleep in individuals with chronic SCI.

Body dysmorphic disorder treatment: about a clinical case

Introduction

Body dysmorphic disorder (BDD) is a relatively common disorder characterized by a preoccupation with non-existent or slight defects in appearance. It was first described in 1886 by Morselli as dysmorphophobia.

Objectives

This work reviews the current available data on BDD and its treatment options and describes a clinical case that reports an improvement in symptomatology after surgery.

Methods

Non-systematic review of the literature with selection of scientific articles published in the past 10 years; by searching Pubmed and Medscape databases using the combination of MeSH descriptors. The following MeSH terms were used: “body dysmorphic disorder”, “dysmorphophobia”. Clinical file consultation.

Results

The usual treatment involves a combination of psychotherapy and pharmacotherapy. Antidepressant medication, mainly selective serotonin reuptake inhibitors (SSRIs) have been used. If the symptoms do not improve, a different SSRI can be considered or clomipramine, venlafaxine or second-generation antipsychotics can be useful.

Conclusions

The role of surgery remains controversial, several studies indicating that the symptoms typically worsen after an aesthetic procedure because the preoccupation shifts to a different body area. However a recent study reported 32 of the 41 patients that underwent surgery were highly satisfied with the outcome. In our clinical case, our patient, a 20-year-old female with non-delusional dysmorphic ideas about her nose initiated treatment with paroxetine with poor response and was, against medical opinion, submitted to a rhinoplasty. Three weeks after the surgery there was an improvement in preoccupation about her nose. More research should be made to clarify the role of surgery in this disorder that often lacks adequate therapeutical response.

Disclosure

No significant relationships.

Seizures and alcohol withdrawal: A literature review

Introduction

Seizures occur in about 3% cases of alcohol withdrawal. They usually appear within 48 hours after abrupt cessation, and are characterized by a reduction in seizure threshold secondary to adaptation to alcohol. More than 50% of individuals will experience a new seizure and in 5% of these cases, progression to a sustained epilepticus status can occur.

Objectives

The aim is to do a review of the literature on alcohol withdrawal and the onset of seizures in individuals with alcohol addiction.

Methods

A literature review was conducted using the PubMed search database.

Results

Alcohol is a central nervous system (CNS) depressant and chronic consumption causes neuroadaptation in order to maintain homeostasis. This adaptation involves the upregulation of excitatory neurotransmitters systems and the downregulation of inhibitory ones. When consumption is abruptly discontinued, the depressive contribution of alcohol to a previously established balance is disrupted, resulting in withdrawal symptoms associated to a generalized CNS’ hyperexcitability state.Critical episodes increase the risk of delirium tremens, a fatal condition in 20% of untreated cases. Thus, the treatment and prevention of seizure recurrences is essential: the clinical guidelines of the American Society of Addiction Medicine 2020, offer an action proposal. Pharmacological therapy after seizures is the preferential treatment: intravenous administration of fast-acting benzodiazepines (lorazepam and diazepam) is the first line treatment.

Conclusions

It is essential to monitor signs and symptoms that alert us to the appearance of seizures associated to alcohol withdrawal, effectively treat these cases, prevent recurrences, and provide a quality follow-up for these patients.

Disclosure

No significant relationships.

POS0908 AUDIOLOGICAL DISTURBANCES IN PATIENTS WITH SYSTEMIC SCLEROSIS: ASSOCIATION WITH CLINICAL MANIFESTATIONS AND NAILFOLD CAPILLARY MICROSCOPIC ABNORMALITIES

Background

Systemic Sclerosis (SSc) is a rare connective tissue disease with several systemic and organ specific manifestations, characterized by immune dysfunction, vascular abnormalities, and fibrosis. The microvascular damage is a prominent feature of SSc, being easily assessed by nailfold video-capillaroscopy (NVC). These vascular changes may result in the involvement of the inner ear as the cochlea is highly sensitive to these changes. Blood changes and hypoxia seem to culminate with necrosis of the cochlear tissue, which is clinically expressed as hypoacusis and tinnitus. Hearing loss and auditory symptoms have been reported in 20 to 40% of SSc patients. The prominence of other symptoms may be a reason for audiovestibular symptoms being neglected in these patients, but this can negatively affect patient’s quality of life (QoL) and social interaction.

Objectives

The aim of this study is to assess the prevalence of audiological disturbances in patients with SSc and to evaluate its relationship with the duration, characteristics, and severity of the disease.

Methods

Cross-sectional study included 24 patients with SSc, who fulfilled ACR/EULAR criteria followed at outpatient rheumatology clinic between 2012 and 2020 and 20 healthy controls. Socio-demographic, clinical data and pattern of NVC were collected. Both groups underwent a complete ear-nose-throat physical examination, pure-tone audiometry, speech audiometry and impedance. QoL was assessed by the European Quality of Life–5 Dimensions (EQ-5D) questionnaire. Descriptive analysis was performed, p-value <0.05 was statistically significant.

Results

Clinical characteristics and audiometric findings of all patients are listed in Table 1. 13% of patients with SSc reported hearing loss and 38% reported tinnitus and vertigo. Similar values were reported in control group with exception to vertigo symptoms (20%). 37.5% patients presented abnormal hearing loss in the pure-tone audiometry compared with 5% of the controls (p=0.02). Sensorineural hearing loss and abnormal speech reception threshold were more common in SSc patients compared to controls (p=0.03; p=0.04). Auditory recruitment was found in 1 SSc patient. There was no correlation between objective hearing loss and type of scleroderma, duration of disease, type of antibodies, skin score, NVC patterns and organ involvement but there were statistically significant differences with history of digital ulcers. We also found middle ear dysfunction: absence of stapedius reflex (20.8%) and abnormal tympanometry (45.8%) in patients with SSc versus control group (p=0.001). The mean value of EQ-VAS was lower in SSc group (63.8±13.1) compared to controls (71.1±11.0) (p=0.04), but without significant differences with the changes in the pure-tone or speech audiometry.

Table 1.

Clinical characteristics and audiometric findings of all patients

SSc n=24Controls n=20pAge, years (mean±SD)58.4±11.455.3±10.30.63Sex (M/F), n5/196/140.49Duration disease (mean±SD)50.3±41.2-Diffuse cutaneous, n (%)7 (29.2)-Anti-Scl70 antibody, n (%)6 (25.0)-Anticentromere antibody, n (%)14 (58.3)-Anti-RNA polymerase III antibody, n (%)3 (12.5)-Pulmonary involvement, n (%)7 (29.2)-Gastrointestinal involvement, n (%)8 (33.3)-Articular involvement, n (%)2 (8.3)-Nailfold video-capillaroscopy pattern-- Nonspecific1 (4.2) Early11 (45.8) Active8 (33.3) Late4 (16.7)Subjective hearing loss, n (%)3 (12.5)3 (15)0.58Tinnitus, n (%)9 (37.5)4 (20)0.41Objective hearing loss, n (%)9 (37.5)1 (5)0.02Sensorineural hearing loss (%)7 (29.2)1 (5)0.03EQ-VAS (mean±SD)63.8±13.171.1±11.00.04

Conclusion

Our study found higher prevalence of inner and middle ear pathologies in SSc patients. It is also important to emphasize the relationship found with history of digital ulcer. In these patients, this type of involvement should be considered both during diagnostic and therapeutic procedures. Further investigation is needed for a better understanding of ear damage in these patients.

Disclosure of Interests

None declared

From Akute Primäre Verruckheit to Bouffée Delirante: The background of Acute Transient Psychosis

Introduction

Ever since the end of the 19th century that descriptions of acute and transient psychosis (ATP) have been found in the literature. Psychiatrists from different countries gave different names for these types of episodes, throughout the ages. Those early descriptions were an important part of the development of the concept of acute and transient psychotic disorders (F23: ICD-10).

Objectives

This review aims to provide historical background of the development of different concepts to describe ATP.

Methods

Non-systematic review of literature on acute and transient psychotic disorders, bouffee delirante, brief psychotic disorder, atypical psychosis.

Results

In 1876, K.Westphal introduced the term akute primäre Verruckheit, refering to a sudden paranoia associated with delusion ideas and hallucinations. In 1895, Magnan described Bouffée delirante, characterized by a recorrent, sudden psychosis with polymorphic symptoms. Later (1924), the term cycloid psychosis was introduced by K.Kleist: phasic psychosis with good prognosis. Different concepts appeared throughout history: psychogenic psychosis (Wimmer,1916); atypical psychosis (Mitsuda,1942), holodisfrenia (Barahona,1957). Nowadays, the classification systems include many of these concepts in the same categories: Schizophreniform disorder, Brief psychotic disorder (DSM-5), and ATP (F23 in ICD-10).

Conclusions

All throughout the History of Psychiatry, there was an evolution of concepts associated to ATP. They were strongly influenced by different time epochs. It is important to have context on the historical background of the concepts used in the contemporaneous Psychiatry. Diagnosis is challenging due to their heterogeneous presentation. There are not many studies available, because of ATP’s low diagnostic stability.

Disclosure

No significant relationships.

Growing use of valproic acid in substance use disorders

Introduction

Valproic acid is an antiepileptic drug used in different fields of Psychiatry. It is known mostly for its use in managing patients with bipolar affective disorder. In psychiatry of addiction, there is still no approved indications for its usage, but it is widely prescribed in treating alcohol and cocaine abuse, due to the existence of studies in these addictions.

Objectives

This review aims to clarify the relation between valproic acid and dependences, particularly cocaine.

Methods

Non-systematic literature review using a PubMed search, using the following key words: “valproate”; “cocaine use”.

Results

Cocaine dependence can decrease GABA levels in humans. Valproic acid has multiple mechanisms that favour the synthesis of GABA, potentiating its release and postsynaptic GABAergic response. Because of this, valproic acid was found effective in promoting abstinence and in reducing the use of cocaine. There are studies that support the valproic acid’s use in alcohol and cocaine dependences. Valproic acid has been shown to be promising in relapse prevention. It has also showed efficacy in the management of impulsivity and irritability, what makes it useful in managing patients with borderline personality disorder – patients at higher risk for alcohol or substance use disorders.

Conclusions

Cocaine addiction involves different phenomena and may respond to distinct pharmacologic approaches. Although some studies need to be confirmed by larger clinical trials, valproic acid seems a promising agent as one of some potential treatments for cocaine dependence. Further studies are required in this field to come to more reliable conclusions.

Disclosure

No significant relationships.

The phenomenology of motivation

Introduction

The concept of motivation pervades our professional and personal lives. Motivation is almost impossible to be observed directly, it is a construct for the interpretation of a behaviour that “calls the attention”.

Objectives

This work reviews the current available data on the phenomenological description of motivation and the abnormalities of motivation.

Methods

Non-systematic review of the literature with selection of scientific articles published in the past 10 years; by searching Pubmed and Medscape databases using the combination of MeSH descriptors. The following MeSH terms were used: “motivation”, “psychopathology”, “phenomenology”.

Results

Abnormalities in motivation may involve diminution or exacerbation. Anhedonia is the absence of pleasure in relation to usually pleasurable activities, it occurs in depression and schizophrenia where the pleasurable intrinsic motivation that acts as incentive for behaviour may be lost. In mania it may be increased so that mundane activities become unduly fascinating and rewarding.

Conclusions

Countless theories have been proposed to explain human motivation but each sheds light on specific aspects of motivation, neglecting others. This diversity creates confusion because most theories have areas of conceptual overlap and disagreement. To facilitate the development of studies, an agreement should be achieved on an operational definition of motivation.

Disclosure

No significant relationships.

That song in my head: a review on Musical Hallucinations

Introduction

Hearing music inside our heads is frequent, however some hear it more vividly, constantly and involuntarily. Musical Hallucinations (MH), first described by Baillarger in 1846, are a complex type of auditory hallucination characterized by perception of melodies, music, or songs.

Objectives

This work aims to review the literature considering MH.

Methods

Pubmed and Google Scholar search using MeSH term “musical hallucinations”

Results

MH occurs in 0.16% of the population. They´re usually perceived as frightening or annoying. Proposed mechanisms include spontaneous activity triggered by sensory deprivation from hearing impairment, like in visual hallucinations in Charles Bonnet syndrome, and some authors even include MH as a subtype of this syndrome. Indeed, 60% of all patients with MH have hearing impairment or deafness. Other less frequent causes include focal brain lesions involving the auditory pathway and cortex, temporal epilepsy, metabolic or drug intoxication. Psychiatric conditions are uncommon but not impossible, especially in affective disorders. MH most frequently consist in familiar tunes, sometimes of personal significance, religious songs (especially in older patients), childhood songs, folk and popular songs from the radio - suggesting that musical perception is never unlearned but represents a “parasitic memory”, an unchangeable memory feature which can be experienced by relevant neuronal circuit stimulation. Most patients with MH were reported to have no extraordinary musical skills.

Conclusions

MH are rare and strongly associated with hearing loss, though investigation of other causes should be sought. Treating the underlying cause is important but remission is not guaranteed.

Disclosure

No significant relationships.

Cannabis use and cognitive impairment in schizophrenia

Introduction

Neurocognitive deficits amongst patients with schizophrenia are considered one of schizophrenia’s central features. These deficits appear to be present from the first episode of psychosis (FEP) and certain cognitive impairments could be components of a genetic vulnerability to schizophrenia. Regarding research on cannabis and cognition in schizophrenia, different studies have assessed neurocognitive functions: memory, attention/vigilance, processing speed, verbal learning, executive functions, and verbal fluency.

Objectives

The aim is to do a review of recent findings concerning the association of cannabis use with cognition in schizophrenia.

Methods

A literature review was conducted using the PubMed search database.

Results

Patients with schizophrenia and concomitant cannabis use are associated with worse performance in immediate verbal learning, and in some studies with worse working memory performance. There is an improvement of verbal memory when they cease the cannabis’ consumption. Regarding attention capacity and memory types assessed, the results are controversial. In FEP, heavy cannabis use during the previous year correlates with slower processing speed. Also, FEP-patients with cannabis use but no family history of psychosis perform worse in executive functions, while those with a family history of psychosis perform better.

Conclusions

The studies of psychosis, cannabis and cognition differ in relevant aspects, which might be connected to the result variability. Therefore, before solid conclusions can be reached, it is important to carry out longitudinal studies to understand the changes in the cognitive variables, which can depend on the pattern of cannabis’ use (concurrent or prior to the FEP). Possible confounding variables that might be present should be acknowledged.

Disclosure

No significant relationships.